PeptideSearch

PNC-27

Very early research

The research is at the earliest stage – mostly cells in a lab dish. It is far too early to say much.

A lab-designed peptide studied in cells for killing cancer cells. Very early research.

The basics

What is it?
PNC-27 joins a piece of the p53 protein to a short membrane-crossing tail. Most of what is published comes from cell studies, and the results are debated.

Can a doctor prescribe this?

No. Pharmacies are not on record as being allowed to make this into a medicine.

The FDA has not approved this as a medicine.

Not FDA approved and not on the U.S. compounding list. A doctor cannot prescribe it.

Official status: Not on the 503A bulks list. Checked 2026-08-04.

Lab suppliers we list: 5

Doses used in research

Taken word for word from the studies and trials listed on this page. This is not a recommendation and not a dose for anyone to take.

No dosing information has been published in the research indexed here.